IA
MXCT icon

IFP Advisors’s MaxCyte MXCT Stock Holding History

IFP Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812 Buy
660
+54
+9% +$54 ﹤0.01% 4566
2026
Q1 		$426 Buy
606
+585
+2,786% +$546 ﹤0.01% 4455
2025
Q4 		$33 Sell
21
-1
-5% -$2 ﹤0.01% 4752
2025
Q3 		$35 Sell
22
-34
-61% -$59 ﹤0.01% 4701
2025
Q2 		$121 Buy
56
+22
+65% +$53 ﹤0.01% 4710
2025
Q1 		$93 Sell
34
-26
-43% -$103 ﹤0.01% 3868
2024
Q4 		$249 Buy
+60
New +$227 ﹤0.01% 3631

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CWM
Cabot Wealth Management Salem, Massachusetts $982M AUM 21.85% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KL
KWMG LLC Overland Park, Kansas $1.38B AUM 33.35% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

IFP Advisors's MXCT Position: Q2 2026 in Review

IFP Advisors increased its MaxCyte (MXCT) stake by 8.9% in Q2 2026, buying an estimated $54 and bringing the position to 660 shares worth $812. The position accounts for ﹤0.01% of the portfolio, ranked #4566.

IFP Advisors first reported a position in MXCT in Q4 2024 and has held it in 7 quarters since. 19 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • IFP Advisors held 660 shares of MaxCyte worth $812 as of Q2 2026.
  • IFP Advisors bought 54 MaxCyte shares in Q2 2026, an estimated $54.
  • MaxCyte made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4566 holding.
  • IFP Advisors first reported a position in MaxCyte in Q4 2024 and has held it in 7 quarters since.
  • 19 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.